The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Reddoch James F. since 2021.
This trader's CIK number is 1814872.
At the time of last reporting, Reddoch James F. was the EVP & Chief Scientific Officer of Royalty Pharma Plc. (stock ticker symbol RPRX).
Also see all insider trading activities at Royalty Pharma Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | RPRX | 0 | $0 | 350,000 | $14,392,748 | 0 | $0 |
| 2021 | RPRX | 0 | $0 | 358,949 | $15,788,733 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-09-28 | RPRX | Sale | 100,000 | 41.23 | 4,122,699 |
| 2022-06-08 | RPRX | Sale | 100,000 | 41.56 | 4,155,899 |
| 2022-05-27 | RPRX | Sale | 75,000 | 41.08 | 3,081,000 |
| 2022-05-19 | RPRX | Sale | 75,000 | 40.44 | 3,033,150 |
| 2021-07-26 | RPRX | Sale | 8,949 | 39.78 | 355,973 |
| 2021-07-26 | RPRX | Sale | 8,949 | 39.78 | 355,973 |
| 2021-07-12 | RPRX | Sale | 100 | 42.04 | 4,204 |
| 2021-07-13 | RPRX | Sale | 17,832 | 42.01 | 749,086 |
| 2021-07-14 | RPRX | Sale | 2 | 42.00 | 84 |
| 2021-07-06 | RPRX | Sale | 30,270 | 42.40 | 1,283,569 |
| 2021-07-07 | RPRX | Sale | 2,192 | 42.01 | 92,085 |
| 2021-07-08 | RPRX | Sale | 40,655 | 42.05 | 1,709,380 |
| 2021-06-02 | RPRX | Sale | 50,000 | 42.13 | 2,106,550 |
| 2021-04-14 | RPRX | Sale | 55,714 | 42.10 | 2,345,615 |
| 2021-04-12 | RPRX | Sale | 359 | 42.32 | 15,192 |
| 2021-03-22 | RPRX | Sale | 43,927 | 46.32 | 2,034,522 |
| 2021-03-02 | RPRX | Sale | 100,000 | 47.37 | 4,736,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reddoch James F. (EVP & Chief Scientific Officer of Royalty Pharma Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.